Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis

被引:15
|
作者
Yang, Chunkun [1 ]
Mu, Yanguang [2 ]
Li, Shuanghong [3 ]
Zhang, Yang [2 ]
Liu, Xiaoyuan [3 ]
Li, Jun [1 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China
[2] Weifang Peoples Hosp, Weifang, Peoples R China
[3] Weifang Hosp Tradit Chinese Med, Weifang, Peoples R China
关键词
tanshinone IIA; vascular endothelial cells; vascular smooth muscle cells; atherosclerosis; plaques; adverse drug reactions; adhesion; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE SYNTHASE; ESTROGEN-RECEPTOR ACTIVATION; SALVIA-MILTIORRHIZA; ATTENUATES ATHEROSCLEROSIS; CHOLESTEROL EFFLUX; INDUCED EXPRESSION; HYDROGEN-PEROXIDE; SIGNALING PATHWAY;
D O I
10.3389/fphar.2023.1321880
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tanshinone IIA (Tan IIA) is a fat-soluble compound extracted from Salvia miltiorrhiza, which has a protective effect against atherosclerosis (AS). Tan IIA can inhibit oxidative stress and inflammatory damage of vascular endothelial cells (VECs) and improve endothelial cell dysfunction. Tan IIA also has a good protective effect on vascular smooth muscle cells (VSMCs). It can reduce vascular stenosis by inhibiting the proliferation and migration of vascular smooth muscle cells (VSMCs), and improve the stability of the fibrous cap of atherosclerotic plaque by inhibiting apoptosis and inflammation of VSMCs. In addition, Tan IIA inhibits the inflammatory response of macrophages and the formation of foam cells in atherosclerotic plaques. In summary, Tan IIA improves AS through a complex pathway. We propose to further study the specific molecular targets of Tan IIA using systems biology methods, so as to fundamentally elucidate the mechanism of Tan IIA. It is worth mentioning that there is a lack of high-quality evidence-based medical data on Tan IIA treatment of AS. We recommend that a randomized controlled clinical trial be conducted to evaluate the exact efficacy of Tan IIA in improving AS. Finally, sodium tanshinone IIA sulfonate (STS) can cause adverse drug reactions in some patients, which needs our attention.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Tanshinone IIA, a melanogenic ingredient basis of Salvia miltiorrhiza Bunge
    Wang, Zhaojing
    Tang, Huihao
    Yang, Lili
    Li, Yiming
    Wu, Huali
    DERMATOLOGICA SINICA, 2021, 39 (01) : 33 - +
  • [2] Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis
    Chen, Zhuo
    Xu, Hao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [3] The regulated profile of noncoding RNAs associated with inflammation by tanshinone IIA on atherosclerosis
    Chen Wenna
    Guo Shengnan
    Li Ximing
    Song Nan
    Wang Dan
    Yu Rui
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 108 (01) : 243 - 252
  • [4] Effect of Combined Administration of Tanshinone IIA and Δ7-stigmastenol on Inflammatory Response in Chinese Mini Swine with Coronary Atherosclerosis
    Li Linfu
    Wang Min
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C5 - C5
  • [5] Tanshinone IIA alleviates atherosclerosis in LDLR-/- mice by regulating efferocytosis of macrophages
    Wang, Jiarou
    Zhang, Yifan
    Feng, Xiaoteng
    Du, Min
    Li, Sijin
    Chang, Xindi
    Liu, Ping
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress
    Chen, Wenying
    Tang, Futian
    Xie, Bailu
    Chen, Shaorui
    Huang, Heqing
    Liu, Peiqing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 674 (2-3) : 359 - 364
  • [7] A CARDIOVASCULAR HERBAL MEDICINE (TANSHINONE IIA) FACILITATES CELLULAR HMGB1 UPTAKE
    Zhang, Y.
    Li, W.
    Zhu, S.
    Li, J.
    Jundoria, A.
    Yang, H.
    Tracey, K.
    Wang, P.
    Sama, A.
    Wang, H.
    SHOCK, 2012, 37 : 25 - 25
  • [8] Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms
    Liu, Qing
    Li, Jianping
    Hartstone-Rose, Adam
    Wang, Jing
    Li, Jiqiang
    Janicki, Joseph S.
    Fan, Daping
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [9] Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
    Wen, Jiexia
    Chang, Yumei
    Huo, Shanshan
    Li, Wenyan
    Huang, Heling
    Gao, Yunhuan
    Lin, Hongyu
    Zhang, Jianlou
    Zhang, Yonghong
    Zuo, Yuzhu
    Cao, Xuebin
    Zhong, Fei
    AGING-US, 2021, 13 (01): : 910 - 932
  • [10] A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment
    Bi, Zhangyang
    Wang, Yayun
    Zhang, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 137